Loading organizations...
§ Venture Capital · Seoul, Seoul-t'ukpyolsi, South Korea
An organization. No specific public information regarding its operational type, services, or market focus is currently available.
Gauss Capital Management is an investment firm operating within the broader financial services sector, though its specific asset classes and primary geographic headquarters currently remain undisclosed in public databases. As a private entity, the organization maintains a highly confidential profile regarding its operational scale, meaning exact figures pertaining to its total assets under management or overall enterprise valuation are not publicly available. Furthermore, the firm has not disclosed its specific client base, institutional partnerships, or portfolio holdings, preventing the identification of recognizable lead investors or notable corporate customers at this time. Industry databases currently lack definitive records detailing the firm's specific market focus, regulatory filings, or internal employee headcount. Consequently, comprehensive historical data regarding Gauss Capital Management is limited, and the exact founding year along with the identities of its original founders remain unverified in standard financial registries.
Gauss Capital Management has 3 tracked investments across 3 companies. The latest tracked deal is $47.0M Series B in PineTree Therapeutics in October 2025.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Oct 28, 2025 | PineTree Therapeutics | $47.0M Series B | — | Atinum Investment, Yohan KIM, Korea Investment Partners, Samho Green Investment, SJ Investment Partners, Smilegate Investment, S&S Investment, Stic Ventures, SV Investment, Widwin Investment |
| May 21, 2024 | Arobot | $2.6M Seed | Hana Ventures | SGC Partners |
| Oct 23, 2020 | iiRcade | $5.5M Seed | Gauss Capital Management | Mirae Asset Venture Investment |